Walleye Capital’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,721
Closed -$73.8K 2442
2024
Q2
$73.8K Buy
+12,721
New +$73.8K ﹤0.01% 2110